SEC Form 4 · accession 0000899243-17-006354
PROTHENA CORP PUBLIC LTD CO · PRTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis J. Selkoe
Director
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.01 per share | Mar 1, 2017 | M | 3,500 | $16.42 | A | 6,345 | D | |
| Ordinary Shares, par value $0.01 per shareF2 | Mar 1, 2017 | S | 3,500 | $59.2469 | D | 2,845 | D | |
| Ordinary Shares, par value $0.01 per share | holding | — | — | — | 1,363 | I | By wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $16.42 | Mar 1, 2017 | M | 3,500 | D | Jul 22, 2014 | Jul 21, 2023 | Ordinary Shares | 3,500 | 14,000 | D |
Explanation of responses
- F1The sale reported on this Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- F2The transaction was executed in multiple trades in prices ranging from $58.70 to $59.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.